These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 9049231)

  • 1. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study.
    Bruno S; Silini E; Crosignani A; Borzio F; Leandro G; Bono F; Asti M; Rossi S; Larghi A; Cerino A; Podda M; Mondelli MU
    Hepatology; 1997 Mar; 25(3):754-8. PubMed ID: 9049231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b.
    Zein NN; Poterucha JJ; Gross JB; Wiesner RH; Therneau TM; Gossard AA; Wendt NK; Mitchell PS; Germer JJ; Persing DH
    Am J Gastroenterol; 1996 Dec; 91(12):2560-2. PubMed ID: 8946986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study.
    Tanaka K; Nagao Y; Ide T; Kumashiro R; Sata M
    Int J Mol Med; 2006 May; 17(5):827-32. PubMed ID: 16596267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
    Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
    Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus genotypes in patients with hepatocellular carcinoma.
    Akkiz H; Colakoğlu S; Köksal F; Korkut H; Hafta A
    J Environ Pathol Toxicol Oncol; 1996; 15(2-4):85-8. PubMed ID: 9216790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis.
    Benvegnù L; Pontisso P; Cavalletto D; Noventa F; Chemello L; Alberti A
    Hepatology; 1997 Jan; 25(1):211-5. PubMed ID: 8985292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of amino-acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b.
    Kobayashi M; Akuta N; Suzuki F; Hosaka T; Sezaki H; Kobayashi M; Suzuki Y; Arase Y; Ikeda K; Watahiki S; Mineta R; Iwasaki S; Miyakawa Y; Kumada H
    J Med Virol; 2010 Jan; 82(1):41-8. PubMed ID: 19950230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
    Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
    Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States.
    Reid AE; Koziel MJ; Aiza I; Jeffers L; Reddy R; Schiff E; Lau JY; Dienstag JL; Liang TJ
    Am J Gastroenterol; 1999 Jun; 94(6):1619-26. PubMed ID: 10364034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and course of small hepatocellular carcinomas in patients with hepatitis C virus types 1 and 2.
    Toyoda H; Kumada T; Nakano S; Takeda I; Sugiyama K; Kiriyama S; Sone Y; Hisanaga Y
    J Med Virol; 2001 Feb; 63(2):120-7. PubMed ID: 11170048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.
    Chan HL; Tse CH; Mo F; Koh J; Wong VW; Wong GL; Lam Chan S; Yeo W; Sung JJ; Mok TS
    J Clin Oncol; 2008 Jan; 26(2):177-82. PubMed ID: 18182659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
    Peng YC; Chan CS; Chen GH
    Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study.
    Bruno S; Crosignani A; Maisonneuve P; Rossi S; Silini E; Mondelli MU
    Hepatology; 2007 Nov; 46(5):1350-6. PubMed ID: 17680653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis.
    Raimondi S; Bruno S; Mondelli MU; Maisonneuve P
    J Hepatol; 2009 Jun; 50(6):1142-54. PubMed ID: 19395111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.